ADRB1 and preeclampsia: In contrast to the previous 2-sample MR study,31 we found some evidence that reduced maternal SBP via ADRB1, a target of β-adrenoceptor–blocking drugs, had a potential causal relationship with lower odds of gestational hypertension, though our estimated OR was implausible.